- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion date, Trial primary completion date: Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - Jun 15, 2023
P1, N=24, Active, not recruiting,
Active, not recruiting --> Completed Trial completion date: Jun 2023 --> Sep 2023 | Trial primary completion date: Jun 2023 --> Jun 2022
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion, Enrollment change: Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - Jun 15, 2023
P1, N=14, Completed,
Trial completion date: Jun 2023 --> Sep 2023 | Trial primary completion date: Jun 2023 --> Jun 2022 Active, not recruiting --> Completed | N=24 --> 14
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion date, Trial primary completion date: Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - Jan 26, 2023
P1, N=24, Active, not recruiting,
Active, not recruiting --> Completed | N=24 --> 14 Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Dec 2022 --> Dec 2023
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion date, Trial primary completion date: Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - Jul 28, 2022
P1, N=24, Active, not recruiting,
Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Dec 2022 --> Dec 2023 Trial completion date: Jun 2022 --> Jun 2023 | Trial primary completion date: Jun 2022 --> Jun 2023
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion date, Trial primary completion date: Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - Feb 25, 2022
P1, N=24, Active, not recruiting,
Trial completion date: Jun 2022 --> Jun 2023 | Trial primary completion date: Jun 2022 --> Jun 2023 Trial completion date: Oct 2021 --> Dec 2022 | Trial primary completion date: Mar 2020 --> Dec 2022
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Enrollment closed: Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - Sep 13, 2021
P1, N=24, Active, not recruiting,
Trial completion date: Oct 2021 --> Dec 2022 | Trial primary completion date: Mar 2020 --> Dec 2022 Recruiting --> Active, not recruiting
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion date, Trial primary completion date: Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - Aug 18, 2021
P1, N=24, Recruiting,
Recruiting --> Active, not recruiting Trial completion date: Nov 2021 --> Jun 2022 | Trial primary completion date: Jun 2021 --> Jun 2022
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial primary completion date: Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - Jan 8, 2021
P1, N=24, Recruiting,
Trial completion date: Nov 2021 --> Jun 2022 | Trial primary completion date: Jun 2021 --> Jun 2022 Trial primary completion date: Dec 2020 --> Jun 2021
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion date: Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - Jan 7, 2021
P1, N=24, Active, not recruiting,
Trial primary completion date: Dec 2020 --> Jun 2021 Trial completion date: Oct 2020 --> Oct 2021
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial primary completion date: Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - Aug 8, 2020
P1, N=24, Recruiting,
Trial completion date: Oct 2020 --> Oct 2021 Trial primary completion date: Jun 2020 --> Dec 2020
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion date: Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - Jul 24, 2020
P1, N=24, Active, not recruiting,
Trial primary completion date: Jun 2020 --> Dec 2020 Trial completion date: Jun 2020 --> Oct 2020
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Enrollment closed: Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - Jan 28, 2020
P1, N=24, Active, not recruiting,
Trial completion date: Jun 2020 --> Oct 2020 Recruiting --> Active, not recruiting
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial completion date, Trial primary completion date: Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - Dec 18, 2019
P1, N=24, Recruiting,
Recruiting --> Active, not recruiting Trial completion date: Mar 2020 --> Jun 2020 | Trial primary completion date: Nov 2019 --> Jun 2020
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Trial primary completion date: Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - Dec 18, 2019
P1, N=24, Recruiting,
Trial completion date: Mar 2020 --> Jun 2020 | Trial primary completion date: Nov 2019 --> Jun 2020 Trial primary completion date: Nov 2019 --> Jun 2020
- |||||||||| psilocybin (SYNP-101) / Ceruvia Lifesci
Phase classification: Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - Feb 4, 2019
P1, N=24, Recruiting,
Trial primary completion date: Nov 2019 --> Jun 2020 Phase classification: P2 --> P1
|
